| RS886044867 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886044869 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS886044875 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS886044878 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, cardiac variant |
| RS886044879 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS886044880 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS886044881 |
ATP7A
|
Health Risk |
Pathogenic |
— |
| RS886044882 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS886044887 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS886044891 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS886044894 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS886044896 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Inborn genetic diseases |
| RS886044897 |
RP2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 2, Retinitis pigmentosa 2 |
| RS886044898 |
ATRX
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886044899 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS886044900 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS886044901 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy 1 |
| RS886044905 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS886044906 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS886044909 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS886044910 |
LOC126861897;MHRT;MYH7
|
Health Risk |
Likely pathogenic |
Distal muscle weakness, Distal muscle weakness |
| RS886044911 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal carcinoma, Hereditary nonpolyposis colorectal neoplasms |
| RS886044912 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Decreased circulating alkaline phosphatase activity, Decreased circulating alkaline phosphatase activity |
| RS886044913 |
ASTN2;TRIM32
|
Health Risk |
Pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS886044914 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Scapulohumeral muscular dystrophy, Scapulohumeral muscular dystrophy |
| RS886044915 |
ANO5
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS886044916 |
DMD
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS886044918 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS886044919 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS886044922 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS886044964 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS886044966 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, Charcot-Marie-Tooth disease type 2 |
| RS886044976 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS886044977 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, Neuroblastoma |
| RS886045115 |
NGF
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital sensory neuropathy with selective loss of small myelinated fibers, Congenital sensory neuropathy with selective loss of small myelinated fibers |
| RS886045197 |
HSD3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS886045205 |
PHGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
PHGDH deficiency, PHGDH deficiency |
| RS886045206 |
PHGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
PHGDH deficiency, PHGDH deficiency |
| RS886045207 |
HMGCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS886045239 |
HJV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS886045251 |
GJA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial fibrillation, familial |
| RS886045338 |
ADAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS886045341 |
ADAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS886045351 |
PKLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase hyperactivity |
| RS886045363 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2B1, Congenital muscular dystrophy due to LMNA mutation |
| RS886045365 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy, Dilated cardiomyopathy 1A |
| RS886045415 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS886045513 |
TBX19
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS886045543 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS886045547 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS886045551 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Budd-Chiari syndrome |
| RS886045580 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS886045594 |
SERPINC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary antithrombin deficiency, Inborn genetic diseases |
| RS886045625 |
LAMC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz |
| RS886045629 |
LAMC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS886045654 |
NCF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS886045677 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS886045682 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS886045687 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS886045712 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperparathyroidism 1, Parathyroid carcinoma |
| RS886045714 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hyperparathyroidism 2 with jaw tumors |
| RS886045751 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS886045759 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS886045770 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS886045833 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS886045834 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2 |
| RS886045868 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS886045870 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Amelogenesis imperfecta type 1A |
| RS886045923 |
FLVCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Posterior column ataxia-retinitis pigmentosa syndrome, Posterior column ataxia-retinitis pigmentosa syndrome |
| RS886045928 |
FLVCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Posterior column ataxia-retinitis pigmentosa syndrome, Posterior column ataxia-retinitis pigmentosa syndrome |
| RS886045971 |
TGFB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS886046018 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Warburg micro syndrome 2, Martsolf syndrome |
| RS886046031 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS886046035 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS886046036 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS886046038 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS886046042 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS886046043 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS886046069 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, COQ8A-related disorder |
| RS886046083 |
AGT
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Inborn genetic diseases |
| RS886046110 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS886046149 |
TBCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoparathyroidism-retardation-dysmorphism syndrome, Hypoparathyroidism-retardation-dysmorphism syndrome |
| RS886046172 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS886046174 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS886046176 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS886046206 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA |
| RS886046217 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Methylcobalamin deficiency type cblG |
| RS886046221 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Methylcobalamin deficiency type cblG |
| RS886046262 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS886046265 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS886046269 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS886046270 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS886046274 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS886046277 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiomyopathy |
| RS886046279 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS886046281 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS886046309 |
RPL11
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 7, Diamond-Blackfan anemia |
| RS886046312 |
HMGCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of hydroxymethylglutaryl-CoA lyase, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS886046313 |
HMGCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS886046318 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary leiomyomatosis and renal cell cancer |